[go: up one dir, main page]

AU4053700A - Enhanced tissue and subcellular delivery of vitamin e compounds - Google Patents

Enhanced tissue and subcellular delivery of vitamin e compounds

Info

Publication number
AU4053700A
AU4053700A AU40537/00A AU4053700A AU4053700A AU 4053700 A AU4053700 A AU 4053700A AU 40537/00 A AU40537/00 A AU 40537/00A AU 4053700 A AU4053700 A AU 4053700A AU 4053700 A AU4053700 A AU 4053700A
Authority
AU
Australia
Prior art keywords
vitamin
compounds
enhanced tissue
subcellular delivery
subcellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40537/00A
Other languages
English (en)
Inventor
Mark Fariss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington State University Research Foundation
Original Assignee
University of Washington
Washington State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington State University Research Foundation filed Critical University of Washington
Publication of AU4053700A publication Critical patent/AU4053700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40537/00A 1999-04-02 2000-03-31 Enhanced tissue and subcellular delivery of vitamin e compounds Abandoned AU4053700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12759399P 1999-04-02 1999-04-02
US60127593 1999-04-02
PCT/US2000/008524 WO2000059488A2 (fr) 1999-04-02 2000-03-31 Administration amelioree de composes de vitamine e au niveau tissulaire et infracellulaire

Publications (1)

Publication Number Publication Date
AU4053700A true AU4053700A (en) 2000-10-23

Family

ID=22430904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40537/00A Abandoned AU4053700A (en) 1999-04-02 2000-03-31 Enhanced tissue and subcellular delivery of vitamin e compounds

Country Status (4)

Country Link
EP (1) EP1169033A2 (fr)
AU (1) AU4053700A (fr)
CA (1) CA2366884A1 (fr)
WO (1) WO2000059488A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE383331T1 (de) 1998-11-12 2008-01-15 Invitrogen Corp Transportreagentien
US8541413B2 (en) 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
KR101506925B1 (ko) * 2004-10-01 2015-03-30 램스코르 인코포레이티드 편리하게 이식가능한 서방형 약물 조성물
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CZ300305B6 (cs) * 2005-12-20 2009-04-15 Heaton, A. S. Farmaceutická kompozice obsahující derivát taxanu se zlepšenou terapeutickou úcinností
JP5396274B2 (ja) * 2006-09-15 2014-01-22 スティーブン・ジョン・ラルフ プロオキシダント抗ガン化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
DE3851842T2 (de) * 1987-10-19 1995-03-02 Liposome Co Inc Wässrige bereitung von liposomenzusammensetzungen.
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9715759D0 (en) * 1997-07-26 1997-10-01 Danbiosyst Uk New emulsion formulations
JPH11335284A (ja) * 1998-05-21 1999-12-07 Isehan:Kk レチノイド類を含有する皮膚外用剤

Also Published As

Publication number Publication date
CA2366884A1 (fr) 2000-10-12
EP1169033A2 (fr) 2002-01-09
WO2000059488A2 (fr) 2000-10-12
WO2000059488A3 (fr) 2001-03-01

Similar Documents

Publication Publication Date Title
AU5259100A (en) Medicament
AU5440901A (en) Cosmetic and/or pharmaceutical preparations
AU6168699A (en) Non-compliant system for delivery of implant material
AU7490200A (en) New and improved formulation for paclitaxel
AU2001227858A1 (en) Delivery of cardiac constraint jacket
AU715620C (en) Therapeutic methods and uses
AU1887401A (en) Medicinal composition
AU3374799A (en) Delivery of an angiogenic substance
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU6715600A (en) Pharmaceutical formulations
AU1730201A (en) Proteoglycans and pharmaceutical compositions comprising them
AU2438400A (en) Cosmetic and/or pharmaceutical preparations
AU4053700A (en) Enhanced tissue and subcellular delivery of vitamin e compounds
AU4293800A (en) Cosmetic and/or pharmaceutical preparations
AU4977300A (en) Pharmaceutical formulations
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
AU1385801A (en) Pharmaceutical formulations
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU3760900A (en) Treatment of menstrual function
AU2214199A (en) Therapeutic liposome-encapsulated immunomodulators
AU4543500A (en) Pharmaceutical compositions and uses
AU1800100A (en) Medicinal preparations
AU3926000A (en) Methods and compositions for drug delivery
AUPQ367699A0 (en) Treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase